QNTM — Quantum Biopharma Ltd.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1771885 ·
Ontario, Canada
Last close
$3.83
Market Cap
$24.51M
52W High
$10.81
52W Low
$2.18
ADV30
410,090
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -2,909,492 | -13,560,299 | 14,926,075 | 4,341,908 | 16,345,974 |
| Dec 2025 | 0 | — | -2,359,801 | -3,026,467 | 11,160,909 | 1,905,357 | 6,058,294 |
| Sep 2025 | 0 | — | -4,658,195 | -5,319,029 | 14,153,228 | 445,944 | 6,646,480 |
| Jun 2025 | 0 | — | -4,913,790 | -9,253,067 | 15,297,031 | 1,497,576 | 13,249,998 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-8,237,012
Investing CF
$-1,952,469
Financing CF
$6,098,966
CapEx
—
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-12.38
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-198,286,170
Inventory
$52,133
Receivables
$231,053
ST Investments
$459,080
EBIT TTM
$-26,338,200
Pretax Income TTM
$-26,956,840
Interest Exp TTM
$618,640
Analysts
1
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -15,317,409 | -26,175,286 | 11,160,909 | 6,058,294 | — | -8,237,012 |
| Dec 2024 | 0 | -15,884,034 | -14,202,724 | 17,119,224 | 6,678,992 | — | -6,876,479 |
| Dec 2023 | 0 | -19,570,114 | -17,902,179 | 17,474,828 | 4,565,566 | — | -10,827,264 |
| Dec 2022 | 0 | -27,429,611 | -23,606,828 | 38,410,656 | 7,868,436 | — | -28,333,273 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-7.80
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RMTI | ROCKWELL MEDICAL, INC. | $24.47M | $0.62 | — |
| RMHI | Retrieve Medical Holdings, Inc. | $24.32M | $0.87 | — |
| TVRD | Tvardi Therapeutics, Inc. | $24.77M | $2.64 | — |
| PTN | PALATIN TECHNOLOGIES INC | $24.22M | $13.61 | — |
| BCTX | BriaCell Therapeutics Corp. | $24.10M | $2.77 | — |
News headlines (Yahoo Finance, 1h cache)
Quantum BioPharma (QNTM) Advances Proprietary Therapy for MS Treatment
2026-06-09 18:51 · Yahoo
Quantum BioPharma (QNTM) Builds Diversified Pipeline Across Neurological and Wellness Markets
2026-06-04 19:30 · Yahoo
Quantum BioPharma (QNTM) Highlights Lucid-MS and unbuzzd(TM) Growth Opportunities on BioMedWire Podcast
2026-06-02 19:50 · Yahoo
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd.
2026-06-02 12:00 · Yahoo
Quantum BioPharma Engages Stocks.news For Investor Relations, Marketing Services And Lead Generation Campaigns
2026-06-02 11:40 · Yahoo
Quantum BioPharma Provides Corporate Update
2026-06-01 23:30 · Yahoo
Quantum BioPharma (QNTM) Reports Midpoint Enrollment Milestone in MS Imaging Study
2026-05-19 18:05 · Yahoo
Quantum BioPharma Reaches Halfway Point in Patient Enrollment in Imaging Study With MGH
2026-05-19 11:21 · Yahoo
Quantum BioPharma Shares Climb as Multiple Sclerosis Imaging Study Advances (QNTM)
2026-05-18 14:37 · Yahoo
Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital
2026-05-18 07:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.